Colgate-Palmolive Company $CL Shares Purchased by ProShare Advisors LLC

ProShare Advisors LLC increased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 4.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,148,142 shares of the company’s stock after purchasing an additional 100,600 shares during the quarter. ProShare Advisors LLC owned 0.27% of Colgate-Palmolive worth $169,746,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of CL. HighPoint Advisor Group LLC lifted its holdings in Colgate-Palmolive by 0.7% in the fourth quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock valued at $1,255,000 after acquiring an additional 109 shares during the period. Sunpointe LLC increased its position in shares of Colgate-Palmolive by 4.0% in the fourth quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock valued at $241,000 after buying an additional 117 shares in the last quarter. Capital Advisors Inc. OK increased its position in shares of Colgate-Palmolive by 1.4% in the fourth quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company’s stock valued at $758,000 after buying an additional 129 shares in the last quarter. Stratos Wealth Advisors LLC increased its position in shares of Colgate-Palmolive by 4.5% in the third quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock valued at $241,000 after buying an additional 130 shares in the last quarter. Finally, Eads & Heald Wealth Management increased its position in shares of Colgate-Palmolive by 0.6% in the fourth quarter. Eads & Heald Wealth Management now owns 20,744 shares of the company’s stock valued at $1,639,000 after buying an additional 132 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 2.0%

Shares of NYSE:CL opened at $89.89 on Tuesday. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. The business has a fifty day moving average of $86.24 and a two-hundred day moving average of $84.82. The stock has a market cap of $72.12 billion, a P/E ratio of 34.98, a PEG ratio of 4.58 and a beta of 0.31. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.03. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm’s quarterly revenue was up 8.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.91 EPS. On average, research analysts expect that Colgate-Palmolive Company will post 3.82 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Monday, April 20th were issued a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, April 20th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 82.49%.

Analysts Set New Price Targets

CL has been the subject of a number of recent analyst reports. UBS Group boosted their price objective on Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Citigroup boosted their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, February 2nd. Weiss Ratings upgraded Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Morgan Stanley restated an “overweight” rating on shares of Colgate-Palmolive in a research report on Monday, May 4th. Finally, Rothschild & Co Redburn set a $100.00 price objective on Colgate-Palmolive and gave the company a “buy” rating in a research report on Tuesday, April 21st. Twelve investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.